The FDA has approved a number of targeted therapies to treat HER2-positive breast cancer, including: Trastuzumab (Herceptin) has been approved…
Read MoreThe FDA has approved a number of targeted therapies to treat HER2-positive breast cancer, including: Trastuzumab (Herceptin) has been approved…
Read MoreTargeted therapy is a type of cancer treatment that works differently to chemotherapy. Chemotherapy attacks all rapidly dividing cells in…
Read MoreTreatments are less invasive when breast cancer is detected at an early stage. Challenges for breast cancer treatment in Nepal…
Read More